BACKGROUND: Mechanical circulatory support devices are used to maintain hemodynamic stability during high-risk percutaneous coronary interventions. Little is known on the effects of such devices on coronary hemodynamics in patients with significant coronary stenosis. We sought to investigate whether mechanical circulatory support in the form of Impella (Abiomed Inc, Danvers, MA) can improve coronary hemodynamics in the presence of a critical coronary stenosis. METHODS AND RESULTS: We examined coronary perfusion pressures and coronary pressure distal to a critical stenosis using a coronary pressure wire in 11 patients (12 coronary lesions) undergoing high-risk percutaneous coronary interventions with the use of mechanical circulatory support...
The ability of interventional cardiologists to identify high-risk percutaneous coronary intervention...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
We sought to evaluate the safety and feasibility of the Impella 2.5 system (Abiomed Inc., Danvers, M...
Background: The use of Impella support is increasingly adopted to "protect" patients with severe cor...
OBJECTIVES: Cardiogenic shock carries high mortality despite advancements in therapeutic interventio...
OBJECTIVE: We evaluated the acute and long-term results of the use of a new intracardiac microaxial ...
OBJECTIVES: Cardiogenic shock carries high mortality despite advancements in therapeutic interventio...
The rate of performing primary percutaneous coronary intervention in patients with complex coronary ...
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogeni...
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogeni...
Background: Percutaneous ventricular-assistance by Impella (IMP) represents an emerging strategy to ...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
bstract: The use of the Impella device in patients with left ventricular (LV) systolic impairment un...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
The ability of interventional cardiologists to identify high-risk percutaneous coronary intervention...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
We sought to evaluate the safety and feasibility of the Impella 2.5 system (Abiomed Inc., Danvers, M...
Background: The use of Impella support is increasingly adopted to "protect" patients with severe cor...
OBJECTIVES: Cardiogenic shock carries high mortality despite advancements in therapeutic interventio...
OBJECTIVE: We evaluated the acute and long-term results of the use of a new intracardiac microaxial ...
OBJECTIVES: Cardiogenic shock carries high mortality despite advancements in therapeutic interventio...
The rate of performing primary percutaneous coronary intervention in patients with complex coronary ...
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogeni...
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogeni...
Background: Percutaneous ventricular-assistance by Impella (IMP) represents an emerging strategy to ...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
bstract: The use of the Impella device in patients with left ventricular (LV) systolic impairment un...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
The ability of interventional cardiologists to identify high-risk percutaneous coronary intervention...
OBJECTIVE: The aim is to evaluate the feasibility of using mechanical circulatory support, specifica...
We sought to evaluate the safety and feasibility of the Impella 2.5 system (Abiomed Inc., Danvers, M...